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Editorial
Determining which patients wil l suffer
complications or die when submitted to pulmonary
resection remains the greatest concern of
pulmonologists and thoracic surgeons. Due to the
increasing incidence of lung cancer cases, the
following types of pulmonary resection are being
employed with ever greater frequency:
segmentectomy; lobectomy (with or without
surgical reconstruction of the bronchus); and
pneumonectomy. They can be associated with
thoracoplasty, the resection of the superior vena
cava, aorta or carina.
The complexity of the resections depends on
changes in the patterns of patients, who are of an
advanced age, smoke (or used to smoke) heavily
and have one or more of the following comorbidities:
varying degrees of emphysema; arterial hypertension;
heart disease; diabetes; and vascular diseases
(peripheral, renal, hepatic or cerebral).
Despite these risks, we cannot counsel against
pulmonary resection, since total resection of the
tumor, evaluated in isolation, still offers the best
results in terms of five-year survival rates. To decrease
these risks, we need to know, with the greatest
possible degree of accuracy, what will occur in the
intra-operative and post-operative periods.
If we have no notion of what will occur post-
operatively, performing a pulmonary resection can
cure the cancer and yet, if the resection is too
extensive, leave the patient a pulmonary invalid.
In addition, some types of pulmonary resections
in some patients will certainly create complications,
thereby increasing the suffering of the patient, who
will spend more time in the hospital, while reducing
the number of available beds and increasing hospital
costs. Nor is it acceptable that patients with stage
IA lung cancer, whose chances for cure are 80%,
suffer complications or die because one or more
risk factors were neglected before surgery, and the
appropriate prophylaxis was not performed. In
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cases of patients with stage IA lung cancer the use
of lobectomy is unacceptable, even anti-ethical,
because it results in morbidity and mortality rates
that are much higher than the nationally and
internationally established means. Full knowledge of
the risk factors is important to continue reducing
morbidity and mortality rates, rather than to justify
the excess of bad results.
The difficulty in not knowing for sure what will
occur with our patients in the intra-operative and
post-operative periods motivated us to conduct a
study on the so-called risk factors. The accurate and
statistically representative establishment of one or
more risk factors results in the adoption of
prophylactic measures (in the pre-operative, intra-
operative and post-operative periods), which will
impede their manifestation or reduce their negative
impacts.
Brazilian authors, such as Saad et al.,(1) Cataneo,(2-3)
and Stanzani et al.(4) have carried out studies on this
subject.
Saad et al., in a prospective study carried out in
145 patients, searched for variables that could be
the cause of pulmonary complications in the first
72 hours after surgery. They concluded, after logistic
regression, that the variables responsible for the
complications were: history of bronchospasm;
decrease in body mass index; number of years
smoking; and surgical time. In that study, the
Torrington-Henderson perioperative respiratory
therapy (PORT) scale did not predict the
complications but aided the selection of patients at
risk for suffering complications.
In his excellent thesis and study, Cataneo
evaluated, among the most accessible tests in the
medical practice (walk test, stair-climbing test and
spirometry), which one was comparable with the
gold standard - ergospirometry - in the prediction
of complications. He concluded that walk tests and
stair-climbing tests were superior to spirometry.
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Stanzani et al. carried out a prospective study
involving 50 patients. Most of them had been
submitted to lobectomy, although others had
undergone lobectomy with surgical reconstruction
of the bronchus, pneumonectomy or bilobectomy.
In that study, 46% of the patients developed
cardiopulmonary complications, 3.3% died, and
20.7% developed air leakage. These results were
similar to the 44%, 2.9%, and 20.6%, respectively,
found by Sánchez et al.(5) in a study published in
this issue of the Brazilian Journal of Pulmonology.
In their study, Stanzani et al. tried to determine
whether the Torrington-Henderson PORT scale and
the Epstein scale would be able to predict
complications. They concluded that both scales
underestimated (to a statistically significant degree)
the occurrence of minor and moderate
complications when the risk was considered low.
Both scales predicted correctly (and significantly)
the greater number of complications in patients
classified as high risk.
The difficulty that the scales described to date
have in accurately predicting complications is
related to the complexity of their application, the
many variables that have to be evaluated and the
fact that they are not designed for use in cases of
pulmonary resection. Due to the fact that they were
developed for clinical diseases, oncological
diseases or abdominal surgeries (which few
pulmonary resections are), such scales do not
distinguish simple resections (lung biopsy) from
more complex resections (pneumonectomy, with
or without carinoplasty, and others).
In their excellent study, presented in this issue
of the Brazilian Journal of Pulmonology, Sánchez
et al.(5) sought to establish a correlation between
the various comorbidities and the incidence of
complications. Although it was a retrospective
study, the potential limitations of this type of
analysis and the large number of analyzed variables
were balanced by the exceptionally large number
of surgical patients analyzed (305), as well as by
an appropriate statistical study. In the univariate
analysis the authors showed that gender, age,
smoking habits, pre-operative chemotherapy,
diabetes, forced expiratory volume in one second
(FEV1), ratio between FEV1 and forced vital capacity,
body mass index (BMI), the PORT scale score and
the Charlson scale score were all associated with
the occurrence of complications.
In the multivariate analysis, only BMI and the
Charlson scale continued to be associated with the
occurrence of complications. Most variables lost
significance in the multivariate analysis because
the authors learned how to block their negative
effects. For instance, early in the experience of
the authors, pre-operative chemotherapy resulted
in high rates of morbidity and mortality. However,
these rates decreased significantly when the volume
and fraction of inspired oxygen were reduced,
together with the administration of corticosteroids,
started at the initiation of anesthesia and continued
for three days. With these measures, the incidence
of complications with chemotherapy is now similar
to that seen without chemotherapy.
Age was also excluded as a risk factor in the
multivariate analysis. However, in my opinion, it is
still very important in two aspects:
a) from an anatomical point of view, the
pulmonary artery wal l  becomes thin and
atherosclerotic with age, increasing the risk of
rupture when dissected or ligated
b) the usual pre-operative tests typically
conducted do not accurately depict the condition
of the coronary and cerebral arteries in elderly
patients. As a consequence, minor episodes of
hypotension during surgery can cause myocardial
or brain infarction.
I believe that we cannot yet rule out age as a
risk factor for complications. However, as we
increasingly perform surgical procedures in patients
over 70 years of age, we learn how to minimize
the effects of age. During surgery, we pay more
attention to the pulmonary artery, and post-
operative peridural anesthesia has become routine.
As a result, the patient suffers less pain and can
walk on the day after surgery, as well as cooperating
more fully during physiotherapy (respiratory and
motor). In addition, early diagnosis and treatment
of depression have now become the norm and
constitute an important factor in reducing
morbidity rates.
The authors found that only two variables, BMI
and the Charlson scale score, maintained their
significance in the detection of post-operative
complications. Table 4 of the article shows that the
mean BMI among patients who suffered
complications was 23.8 kg/m2, compared with 25.3
kg/m2 among those who did not suffer complications
- a small but significant difference. These means are
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above what the authors considered low BMI (18.5
kg/m2), and we can see that 95% of patients that
suffered complications presented BMIs between 15
kg/m2 and 32.6 kg/m2. Therefore, few were
considered low-weight patients. It is not unusual for
an individual with lung cancer to lose weight. When
weight loss occurs, the tumor is large, typically
presenting necrosis or abscess, and is likely to be
releasing tumor necrosis factors and other toxins.
Although BMI was an important and significant factor
in this study, I believe that, in general, it does not
allow us to predict complications. The authors should
have defined a minimum BMI to predict
complications.
As for the Charlson scale, although it is
composed of various comorbidities, only one
variable was considered. Therefore, it did not
simplify the search for few risk factors to be
analyzed. The Charlson scale was developed to
analyze comorbidities in oncology. Therefore, it
has no specificity for pulmonary resection. The
authors concluded what we already knew: a
decrease in FEV1 and the ratio between FEV1 and
forced vital capacity are important factors in the
development of complications and in mortality.
They concluded that patients with moderate or
severe emphysema (FEV1 < 50%) presented more
complications and more often died.
In relation to post-operative complications, the
authors showed that air leakage (bronchial fistula)
was of significant importance for the development
of other complications, for increases in mortality
rates and for the duration of hospital stays. This
conclusion obliges thoracic surgeons to seek new
solutions in order to impede or reduce air leakage.
When such solutions are found, patients spend less
time in the hospital and chest tube(s) are left in
place for fewer days. In addition, patients suffer
less pain, present less infection and less often
develop empyema.
Pulmonologists and thoracic surgeons will
certainly consult the study of Sánchez et al. in
search of data that can predict what will occur in
their patients during and after surgery. However,
we still do not have a scale designed specifically
for pulmonary resections. Such a scale should be
developed through the analysis of a large number
of patients in a prospective study that separates
the most important factor or factors for every type
of resection: anatomic segmentectomy; lobectomy
(and its variants); pneumonectomy; and resections
accompanied by the resection of the thoracic wall,
superior vena cava, left atrium, aorta or carina. In
the discussion of their article, Stanzani et al. stated
that “Ideally, the new scale should contain few
variables, favor clinical aspects, and should not
need complex mathematic calculations to reach
the risk score".
Finally, we should always bear in mind that even
if we can devise an ideal scale, it will not be
definitive. Certainly, with the passage of time, it
will need to be reviewed, since aspects such as
diagnosis, treatment, intra-operative care and post-
operative care are under constant technical
improvement, as well as because patients want to
live longer but also want to preserve their quality
of life. We should also be aware of the fact that
risk scales are not developed to justify our failures
but to continually reduce the rates of morbidity
and mortality.
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